{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T12:15:26Z","timestamp":1791980126992,"version":"4.4.0"},"reference-count":79,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1097\/tp.0000000000001050","type":"journal-article","created":{"date-parts":[[2016,3,5]],"date-time":"2016-03-05T18:14:15Z","timestamp":1457201655000},"page":"1815-1826","source":"Crossref","is-referenced-by-count":35,"title":["Antifungal Prophylaxis in Lung Transplant Recipients"],"prefix":"10.1097","volume":"100","author":[{"given":"Twisha S.","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory A.","family":"Eschenauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda J.","family":"Stuckey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peggy L.","family":"Carver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-12-20210129","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1080\/13693780701200372","article-title":"Fungal infections in solid organ transplantation","volume":"45","author":"Silveira","year":"2007","journal-title":"Med Mycol"},{"key":"R2-12-20210129","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.healun.2013.08.007","article-title":"The Registry of the International Society for Heart and Lung Transplantation: thirtieth adult lung and heart-lung transplant report\u20142013; focus theme: age","volume":"32","author":"Yusen","year":"2013","journal-title":"J Heart Lung Transplant"},{"key":"R3-12-20210129","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1086\/651262","article-title":"Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET)","volume":"50","author":"Pappas","year":"2010","journal-title":"Clin Infect Dis"},{"key":"R4-12-20210129","doi-asserted-by":"crossref","first-page":"S180","DOI":"10.1111\/j.1600-6143.2009.02910.x","article-title":"Invasive Aspergillosis in solid organ transplant recipients","volume":"9","author":"Singh","year":"2009","journal-title":"Am J Transplant"},{"key":"R5-12-20210129","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1111\/ajt.12691","article-title":"Epidemiology of invasive mold infections in lung transplant recipients","volume":"14","author":"Doligalski","year":"2014","journal-title":"Am J Transplant"},{"key":"R6-12-20210129","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/tid.12337","article-title":"Practice variation in Aspergillus prophylaxis and treatment among lung transplant centers: a national survey","volume":"17","author":"He","year":"2015","journal-title":"Transpl Infect Dis"},{"key":"R7-12-20210129","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1034\/j.1399-3062.2002.t01-2-02002.x","article-title":"The incidence of invasive aspergillosis among solid organ transplant recipients and implications for prophylaxis in lung transplants","volume":"4","author":"Minari","year":"2002","journal-title":"Transpl Infect Dis"},{"key":"R8-12-20210129","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1399-3062.2006.00156.x","article-title":"Variation in antifungal prophylaxis strategies in lung transplantation","volume":"8","author":"Husain","year":"2006","journal-title":"Transpl Infect Dis"},{"key":"R9-12-20210129","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-6143.2010.03375.x","article-title":"Antifungal prophylaxis in lung transplantation\u2014a world-wide survey","volume":"11","author":"Neoh","year":"2011","journal-title":"Am J Transplant"},{"key":"R10-12-20210129","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/ajt.12115","article-title":"Aspergillosis in solid organ transplantation","volume":"13","author":"Singh","year":"2013","journal-title":"Am J Transplant"},{"key":"R11-12-20210129","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1086\/375822","article-title":"Opportunistic mycelial fungal infections in organ transplant recipients: emerging importance of non-Aspergillus mycelial fungi","volume":"37","author":"Husain","year":"2003","journal-title":"Clin Infect Dis"},{"key":"R12-12-20210129","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.ccm.2005.06.001","article-title":"Non-Aspergillus fungal pneumonia in transplant recipients","volume":"26","author":"Costa","year":"2005","journal-title":"Clin Chest Med"},{"key":"R13-12-20210129","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.jinf.2012.08.003","article-title":"Clinical epidemiology of 960 patients with invasive aspergillosis from the PATH Alliance registry","volume":"65","author":"Steinbach","year":"2012","journal-title":"J Infect"},{"key":"R14-12-20210129","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1111\/j.1600-6143.2012.04100.x","article-title":"Donor-derived fungal infections in organ transplant recipients: guidelines of the American Society of Transplantation, infectious diseases community of practice","volume":"12","author":"Singh","year":"2012","journal-title":"Am J Transplant"},{"key":"R15-12-20210129","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1378\/chest.119.1.169","article-title":"Spectrum of aspergillus infection in lung transplant recipients: case series and review of the literature","volume":"119","author":"Mehrad","year":"2001","journal-title":"Chest"},{"key":"R16-12-20210129","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1399-3062.2010.00492.x","article-title":"Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients","volume":"12","author":"Neofytos","year":"2010","journal-title":"Transpl Infect Dis"},{"key":"R17-12-20210129","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1378\/chest.112.5.1160","article-title":"Aspergillus airway colonization and invasive disease after lung transplantation","volume":"112","author":"Cahill","year":"1997","journal-title":"Chest"},{"key":"R18-12-20210129","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1086\/430602","article-title":"Risk factors for invasive aspergillosis in solid-organ transplant recipients: a case-control study","volume":"41","author":"Gavalda","year":"2005","journal-title":"Clin Infect Dis"},{"key":"R19-12-20210129","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1007\/s10096-007-0376-3","article-title":"Aspergillus infection in lung transplant patients: incidence and prognosis","volume":"26","author":"Iversen","year":"2007","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R20-12-20210129","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1111\/j.1600-6143.2006.01548.x","article-title":"Voriconazole prophylaxis in lung transplant recipients","volume":"6","author":"Husain","year":"2006","journal-title":"Am J Transplant"},{"key":"R21-12-20210129","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1086\/514599","article-title":"Cytomegalovirus infection is a risk factor for invasive aspergillosis in lung transplant recipients","volume":"26","author":"Husni","year":"1998","journal-title":"Clin Infect Dis"},{"key":"R22-12-20210129","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/S1053-2498(01)00364-3","article-title":"Nebulized amphotericin B prophylaxis for Aspergillus infection in lung transplantation: study of risk factors","volume":"20","author":"Monforte","year":"2001","journal-title":"J Heart Lung Transplant"},{"key":"R23-12-20210129","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1378\/chest.114.5.1321","article-title":"Pulmonary aspergillosis in cystic fibrosis lung transplant recipients","volume":"114","author":"Nunley","year":"1998","journal-title":"Chest"},{"key":"R24-12-20210129","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S1053-2498(02)00477-1","article-title":"Aspergillus infections after lung transplantation: clinical differences in type of transplant and implications for management","volume":"22","author":"Singh","year":"2003","journal-title":"J Heart Lung Transplant"},{"key":"R25-12-20210129","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1097\/00007890-199603270-00013","article-title":"Aspergillus infection in single and double lung transplant recipients","volume":"61","author":"Westney","year":"1996","journal-title":"Transplantation"},{"key":"R26-12-20210129","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/00007890-200101270-00013","article-title":"Hypogammaglobulinemia in lung transplant recipients","volume":"71","author":"Goldfarb","year":"2001","journal-title":"Transplantation"},{"key":"R27-12-20210129","first-page":"774","article-title":"Airway stenoses after lung transplantation: management with expanding metal stents","volume":"13","author":"Higgins","year":"1994","journal-title":"J Heart Lung Transplant"},{"key":"R28-12-20210129","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1432-2277.2006.00411.x","article-title":"Outbreak of aspergillosis infections among lung transplant recipients","volume":"20","author":"Raviv","year":"2007","journal-title":"Transpl Int"},{"key":"R29-12-20210129","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1469-0691.2005.01128.x","article-title":"Aspergillus infections in lung transplant recipients: risk factors and outcome","volume":"11","author":"Sol\u00e9","year":"2005","journal-title":"Clin Microbiol Infect"},{"key":"R30-12-20210129","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/01.TP.0000437434.42851.d4","article-title":"Pretransplant Aspergillus colonization of cystic fibrosis patients and the incidence of post-lung transplant invasive aspergillosis","volume":"97","author":"Luong","year":"2014","journal-title":"Transplantation"},{"key":"R31-12-20210129","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.healun.2009.11.603","article-title":"Feasibility, tolerability, and outcomes of nebulized liposomal amphotericin B for Aspergillus infection prevention in lung transplantation","volume":"29","author":"Monforte","year":"2010","journal-title":"J Heart Lung Transplant"},{"key":"R32-12-20210129","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0041-1345(96)00363-6","article-title":"Significant reduction in the number of fungal infections after lung-, heart-lung, and heart transplantation using aerosolized amphotericin B prophylaxis","volume":"29","author":"Reichenspurner","year":"1997","journal-title":"Transplant Proc"},{"key":"R33-12-20210129","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1128\/AAC.40.9.2217","article-title":"Systemic availability of itraconazole in lung transplantation","volume":"40","author":"Patterson","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"R34-12-20210129","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1016\/j.healun.2005.05.003","article-title":"Itraconazole prophylaxis in lung transplant recipients receiving tacrolimus (FK 506): efficacy and drug interaction","volume":"24","author":"Shitrit","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"R35-12-20210129","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1399-3062.2007.00209.x","article-title":"Safety of aerosolized liposomal versus deoxycholate amphotericin B formulations for prevention of invasive fungal infections following lung transplantation: a retrospective study","volume":"9","author":"Lowry","year":"2007","journal-title":"Transpl Infect Dis"},{"key":"R36-12-20210129","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1016\/j.transproceed.2008.09.020","article-title":"Efficiency and safety of inhaled amphotericin B lipid complex (Abelcet) in the prophylaxis of invasive fungal infections following lung transplantation","volume":"40","author":"Borro","year":"2008","journal-title":"Transplant Proc"},{"key":"R37-12-20210129","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1111\/j.1600-6143.2009.02734.x","article-title":"Antifungal prophylaxis with voriconazole or itraconazole in lung transplant recipients: hepatotoxicity and effectiveness","volume":"9","author":"Cadena","year":"2009","journal-title":"Am J Transplant"},{"key":"R38-12-20210129","first-page":"399","article-title":"Fungal infection in heart-lung transplant recipients receiving single-agent prophylaxis with itraconazole","volume":"9","author":"Hayes","year":"2011","journal-title":"Exp Clin Transplant"},{"key":"R39-12-20210129","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1592\/phco.31.6.537","article-title":"Invasive fungal infections in lung transplant recipients not receiving routine systemic antifungal prophylaxis: 12-year experience at a university lung transplant center","volume":"31","author":"Pinney","year":"2011","journal-title":"Pharmacotherapy"},{"key":"R40-12-20210129","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/TP.0b013e318255f864","article-title":"A targeted peritransplant antifungal strategy for the prevention of invasive fungal disease after lung transplantation: a sequential cohort analysis","volume":"94","author":"Koo","year":"2012","journal-title":"Transplantation"},{"key":"R41-12-20210129","doi-asserted-by":"crossref","first-page":"835","DOI":"10.3109\/00365548.2012.691207","article-title":"Use of prophylactic voriconazole for three months after lung transplantation does not reduce infection with Aspergillus: a retrospective study of 147 patients","volume":"44","author":"Tofte","year":"2012","journal-title":"Scand J Infect Dis"},{"key":"R42-12-20210129","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/tid.12071","article-title":"Preemptive treatment with voriconazole in lung transplant recipients","volume":"15","author":"Neoh","year":"2013","journal-title":"Transpl Infect Dis"},{"key":"R43-12-20210129","doi-asserted-by":"crossref","first-page":"4459","DOI":"10.1016\/j.transproceed.2010.09.116","article-title":"Control of early Aspergillus mortality after lung transplantation: outcome and risk factors","volume":"42","author":"Eriksson","year":"2010","journal-title":"Transplant Proc"},{"key":"R44-12-20210129","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/tid.12187","article-title":"Itraconazole prophylaxis for invasive Aspergillus infection in lung transplantation","volume":"16","author":"Kato","year":"2014","journal-title":"Transpl Infect Dis"},{"key":"R45-12-20210129","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1016\/S0041-1345(97)00546-0","article-title":"Dose adjustment and cost of itraconazole prophylaxis in lung transplant recipients receiving cyclosporine and tacrolimus (FK 506)","volume":"29","author":"Kramer","year":"1997","journal-title":"Transplant Proc"},{"key":"R46-12-20210129","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1034\/j.1399-3003.1999.13a33.x","article-title":"Pre-emptive therapy with azoles in lung transplant patients. Geneva Lung Transplantation Group","volume":"13","author":"Hamacher","year":"1999","journal-title":"Eur Respir J"},{"key":"R47-12-20210129","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/00007890-200108150-00036","article-title":"Safety of aerosolized amphotericin B lipid complex in lung transplant recipients","volume":"72","author":"Palmer","year":"2001","journal-title":"Transplantation"},{"key":"R48-12-20210129","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1128\/AAC.05219-11","article-title":"Prospective, observational study of voriconazole therapeutic drug monitoring among lung transplant recipients receiving prophylaxis: factors impacting levels of and associations between serum troughs, efficacy, and toxicity","volume":"56","author":"Mitsani","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"R49-12-20210129","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1378\/chest.115.5.1301","article-title":"Antifungal prophylaxis during the early postoperative period of lung transplantation. Valencia Lung Transplant Group","volume":"115","author":"Calvo","year":"1999","journal-title":"Chest"},{"key":"R50-12-20210129","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1439-0507.2005.01112.x","article-title":"Surveillance of invasive mold infections in lung transplant recipients: effect of antimycotic prophylaxis with itraconazole and voriconazole","volume":"48","author":"Mattner","year":"2005","journal-title":"Mycoses"},{"key":"R51-12-20210129","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/01.TP.0000101516.08327.A9","article-title":"Comparative safety of amphotericin B lipid complex and amphotericin B deoxycholate as aerosolized antifungal prophylaxis in lung-transplant recipients","volume":"77","author":"Drew","year":"2004","journal-title":"Transplantation"},{"key":"R52-12-20210129","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1007\/s11908-013-0380-y","article-title":"Anti-Aspergillus prophylaxis in lung transplantation: a systematic review and meta-analysis","volume":"15","author":"Bhaskaran","year":"2013","journal-title":"Curr Infect Dis Rep"},{"key":"R53-12-20210129","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1111\/ajt.12401","article-title":"What is the impact of hypogammaglobulinemia on the rate of infections and survival in solid organ transplantation? A meta-analysis","volume":"13","author":"Florescu","year":"2013","journal-title":"Am J Transplant"},{"key":"R54-12-20210129","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.1399-3062.2007.00290.x","article-title":"Meta-analysis of nebulized amphotericin B to prevent or treat pulmonary aspergillosis in immunosuppressed animals","volume":"10","author":"Ho","year":"2008","journal-title":"Transpl Infect Dis"},{"key":"R55-12-20210129","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1097\/01.TP.0000054233.60100.7A","article-title":"Nebulized amphotericin B concentration and distribution in the respiratory tract of lungtransplanted patients","volume":"75","author":"Monforte","year":"2003","journal-title":"Transplantation"},{"key":"R56-12-20210129","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.healun.2008.11.004","article-title":"Nebulized liposomal amphotericin B prophylaxis for Aspergillus infection in lung transplantation: pharmacokinetics and safety","volume":"28","author":"Monforte","year":"2009","journal-title":"J Heart Lung Transplant"},{"key":"R57-12-20210129","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1097\/TP.0b013e3181f995ea","article-title":"Intrapulmonary disposition of amphotericin B after aerosolized delivery of amphotericin B lipid complex (Abelcet; ABLC) in lung transplant recipients","volume":"90","author":"Husain","year":"2010","journal-title":"Transplantation"},{"key":"R58-12-20210129","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1378\/chest.08-1339","article-title":"DIagnosis and outcome of early pleural space infection following lung transplantation","volume":"135","author":"Wahidi","year":"2009","journal-title":"Chest"},{"key":"R59-12-20210129","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1592\/phco.26.12.1730","article-title":"Factors influencing the magnitude and clinical significance of drug interactions between azole antifungals and select immunosuppressants","volume":"26","author":"Saad","year":"2006","journal-title":"Pharmacotherapy"},{"key":"R60-12-20210129","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/petr.12263","article-title":"Antifungal prophylaxis in pediatric lung transplantation: an international multicenter survey","volume":"18","author":"Mead","year":"2014","journal-title":"Pediatr Transplant"},{"key":"R61-12-20210129","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1183\/09031936.95.08081263","article-title":"Deposition of amphotericin B aerosols in pulmonary aspergilloma","volume":"8","author":"Diot","year":"1995","journal-title":"Eur Respir J"},{"key":"R62-12-20210129","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1086\/504492","article-title":"Pharmacology of Systemic Antifungal Agents","volume":"43","author":"Ashley","year":"2006","journal-title":"Clinical Infectious Diseases"},{"key":"R63-12-20210129","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1128\/AAC.01657-09","article-title":"Systematic review and meta-analysis of the tolerability and hepatotoxicity of antifungals in empirical and definitive therapy for invasive fungal infection","volume":"54","author":"Wang","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"R64-12-20210129","doi-asserted-by":"crossref","first-page":"805","DOI":"10.4065\/mcp.2011.0247","article-title":"Current concepts in antifungal pharmacology","volume":"86","author":"Lewis","year":"2011","journal-title":"Mayo Clin Proc"},{"key":"R65-12-20210129","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1093\/cid\/cis437","article-title":"Challenging recommended oral and intravenous voriconazole doses for improved efficacy and safety: population pharmacokinetics-based analysis of adult patients with invasive fungal infections","volume":"55","author":"Pascual","year":"2012","journal-title":"Clin Infect Dis"},{"key":"R66-12-20210129","doi-asserted-by":"crossref","first-page":"e182","DOI":"10.1093\/cid\/cit600","article-title":"A multistep voriconazole-related phototoxic pathway may lead to skin carcinoma: results from a french nationwide study","volume":"57","author":"Epaulard","year":"2013","journal-title":"Clin Infect Dis"},{"key":"R67-12-20210129","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.healun.2012.02.033","article-title":"High cumulative dose exposure to voriconazole is associated with cutaneous squamous cell carcinoma in lung transplant recipients","volume":"31","author":"Singer","year":"2012","journal-title":"J Heart Lung Transplant"},{"key":"R68-12-20210129","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1111\/j.1524-4725.2012.02418.x","article-title":"Duration of voriconazole exposure: an independent risk factor for skin cancer after lung transplantation","volume":"38","author":"Zwald","year":"2012","journal-title":"Dermatol Surg"},{"key":"R69-12-20210129","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.medmal.2011.09.016","article-title":"Phototoxicity and photocarcinogenesis associated with voriconazole","volume":"41","author":"Epaulard","year":"2011","journal-title":"Med Mal Infect"},{"key":"R70-12-20210129","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s00256-010-0997-y","article-title":"Medication-induced periostitis in lung transplant patients: periostitis deformans revisited","volume":"40","author":"Chen","year":"2011","journal-title":"Skeletal Radiol"},{"key":"R71-12-20210129","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/tid.12088","article-title":"Multifocal periostitis as a complication of chronic use of voriconazole in a lung transplant recipient","volume":"15","author":"Tedja","year":"2013","journal-title":"Transpl Infect Dis"},{"key":"R72-12-20210129","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1111\/j.1600-6143.2009.02837.x","article-title":"Periostitis secondary to prolonged voriconazole therapy in lung transplant recipients","volume":"9","author":"Wang","year":"2009","journal-title":"Am J Transplant"},{"key":"R73-12-20210129","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.healun.2012.05.003","article-title":"Increased incidence of cutaneous squamous cell carcinoma in lung transplant recipients taking long-term voriconazole","volume":"31","author":"Feist","year":"2012","journal-title":"J Heart Lung Transplant"},{"key":"R74-12-20210129","doi-asserted-by":"crossref","first-page":"3609","DOI":"10.1128\/AAC.01396-09","article-title":"Steady-state intrapulmonary pharmacokinetics and pharmacodynamics of posaconazole in lung transplant recipients","volume":"54","author":"Conte","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"R75-12-20210129","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1093\/jac\/dks268","article-title":"A new solid oral tablet formulation of posaconazole: a randomized clinical trial to investigate rising single- and multiple-dose pharmacokinetics and safety in healthy volunteers","volume":"67","author":"Krishna","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"R76-12-20210129","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.1128\/AAC.01647-09","article-title":"Intrapulmonary pharmacokinetics and pharmacodynamics of micafungin in adult lung transplant patients","volume":"54","author":"Walsh","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"R77-12-20210129","first-page":"163","article-title":"Profile of isavuconazole and its potential in the treatment of severe invasive fungal infections","volume":"6","author":"Falci","year":"2013","journal-title":"Infect Drug Resist"},{"key":"R78-12-20210129","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1592\/phco.31.1.52","article-title":"Nebulizer delivery of micafungin aerosols","volume":"31","author":"Alexander","year":"2011","journal-title":"Pharmacotherapy"},{"key":"R79-12-20210129","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1128\/AAC.01657-08","article-title":"Inhaled voriconazole for prevention of invasive pulmonary aspergillosis","volume":"53","author":"Tolman","year":"2009","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000001050","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T07:22:17Z","timestamp":1620976937000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007890-201609000-00012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":79,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000001050","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]}}}